levofloxacin has been researched along with Cirrhosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, TH; Chuang, YC; Sheng, WH; Wang, JT | 1 |
| Bhushan, S; Hedger, MP; Kautz, J; Kispert, A; Klein, B; Loveland, KL; Meinhardt, A; Middendorff, R; Pant, S; Pilatz, A; Rudat, C; Wijayarathna, R | 1 |
| Higgins, PD; Horowitz, JC; Johnson, LA; Luke, A; Moons, DS; Sauder, K | 1 |
3 other study(ies) available for levofloxacin and Cirrhosis
| Article | Year |
|---|---|
Clinical characteristics and outcomes of non-cystic fibrosis patients with Burkholderia cepacia complex bacteremia at a medical center in Taiwan.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Burkholderia cepacia; Burkholderia cepacia complex; Burkholderia Infections; Cystic Fibrosis; Fibrosis; Hospitals; Humans; Levofloxacin; Retrospective Studies; Taiwan; Trimethoprim | 2022 |
Dexamethasone improves therapeutic outcomes in a preclinical bacterial epididymitis mouse model.
Topics: Adaptive Immunity; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Bacterial Load; Cytokines; Dexamethasone; Drug Evaluation, Preclinical; Drug Therapy, Combination; Epididymis; Epididymitis; Epithelial-Mesenchymal Transition; Fibrosis; Humans; Immunoglobulin G; Immunoglobulin M; Infertility, Male; Levofloxacin; Male; Mice, Inbred C57BL | 2019 |
Intestinal fibrosis is reduced by early elimination of inflammation in a mouse model of IBD: impact of a "Top-Down" approach to intestinal fibrosis in mice.
Topics: Actins; Analysis of Variance; Animals; Anti-Infective Agents; Cecum; Colitis; Colon; Cytokines; Female; Fibrosis; Levofloxacin; Mice; Mice, Inbred CBA; Ofloxacin; Salmonella Infections, Animal; Salmonella typhimurium; Time Factors | 2012 |